Featuring

Paul Hudson
Chief Executive Officer

Jean-Baptiste de Chatillon
Chief Financial Officer

Bill Sibold
Specialty Care

Olivier Charmeil
General Medicines

John Reed
R&D

Thomas Triomphe
Vaccines

Julie van Ongevalle
Consumer Healthcare

Roy Papatheodorou
General Counsel

Highlights

“Our exceptional results for the third quarter demonstrate that Sanofi is on the right path. We delivered remarkable sales growth and our commitment to breakthrough science is bearing fruit as we achieved key regulatory milestones for three of our priority medicines.”

Paul Hudson, Chief Executive Officer

Webinar

14:30 -16:00 CET | 8:30am – 10am EST

Downloads available

Contacts

Investor Relations
 investor.relations (at) sanofi.com 
 More contact information

Share